Barclays PLC Reaffirms “Hold” Rating for Colgate-Palmolive Company (CL)
CL has been the subject of several other research reports. Bank of America Corporation upgraded shares of Colgate-Palmolive Company from a neutral rating to a buy rating and boosted their price target for the company from $70.86 to $80.00 in a report on Monday, September 12th. RBC Capital Markets set a $71.00 price target on shares of Colgate-Palmolive Company and gave the company a hold rating in a report on Monday, January 2nd. B. Riley reaffirmed a neutral rating and issued a $78.00 price objective on shares of Colgate-Palmolive Company in a research report on Wednesday, November 2nd. Zacks Investment Research downgraded shares of Colgate-Palmolive Company from a hold rating to a sell rating in a research report on Tuesday, December 27th. Finally, Wells Fargo & Company reaffirmed a market perform rating on shares of Colgate-Palmolive Company in a research report on Tuesday, November 15th. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and three have issued a buy rating to the stock. Colgate-Palmolive Company has a consensus rating of Hold and a consensus price target of $75.59.
Shares of Colgate-Palmolive Company (NYSE:CL) traded down 0.12% on Tuesday, reaching $65.77. 415,763 shares of the company were exchanged. The stock has a market capitalization of $58.46 billion, a price-to-earnings ratio of 43.02 and a beta of 0.67. The firm’s 50 day moving average price is $65.98 and its 200 day moving average price is $70.98. Colgate-Palmolive Company has a 52 week low of $61.40 and a 52 week high of $75.38.
Colgate-Palmolive Company (NYSE:CL) last posted its quarterly earnings results on Thursday, October 27th. The company reported $0.73 EPS for the quarter, meeting the consensus estimate of $0.73. Colgate-Palmolive Company had a net margin of 8.96% and a return on equity of 6,924.14%. The business earned $3.87 billion during the quarter, compared to analyst estimates of $3.94 billion. During the same quarter in the previous year, the business posted $0.80 EPS. The company’s quarterly revenue was down 3.3% compared to the same quarter last year. Equities research analysts anticipate that Colgate-Palmolive Company will post $2.81 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This report was published by Watch List News and is the propert of of Watch List News. If you are viewing this report on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The correct version of this report can be viewed at http://www.watchlistnews.com/barclays-plc-reaffirms-hold-rating-for-colgate-palmolive-company-cl/1059969.html.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 15th. Stockholders of record on Monday, January 23rd will be issued a $0.39 dividend. This represents a $1.56 annualized dividend and a dividend yield of 2.37%. The ex-dividend date of this dividend is Thursday, January 19th. Colgate-Palmolive Company’s dividend payout ratio (DPR) is currently 101.96%.
In related news, insider Jennifer Daniels sold 7,072 shares of the business’s stock in a transaction on Tuesday, December 13th. The shares were sold at an average price of $66.78, for a total value of $472,268.16. Following the completion of the transaction, the insider now directly owns 37,463 shares in the company, valued at approximately $2,501,779.14. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Patricia Verduin sold 3,834 shares of the business’s stock in a transaction on Monday, October 17th. The shares were sold at an average price of $72.39, for a total transaction of $277,543.26. Following the completion of the transaction, the insider now owns 55,013 shares of the company’s stock, valued at $3,982,391.07. The disclosure for this sale can be found here. 1.05% of the stock is currently owned by insiders.
Institutional investors have recently bought and sold shares of the stock. WMS Partners LLC boosted its position in Colgate-Palmolive Company by 7.0% in the second quarter. WMS Partners LLC now owns 7,278 shares of the company’s stock valued at $533,000 after buying an additional 474 shares in the last quarter. Fundsmith LLP boosted its position in Colgate-Palmolive Company by 7.0% in the second quarter. Fundsmith LLP now owns 1,384,087 shares of the company’s stock valued at $100,785,000 after buying an additional 90,358 shares in the last quarter. Toronto Dominion Bank boosted its position in Colgate-Palmolive Company by 33.7% in the third quarter. Toronto Dominion Bank now owns 82,251 shares of the company’s stock valued at $6,106,000 after buying an additional 20,733 shares in the last quarter. BB&T Corp boosted its position in Colgate-Palmolive Company by 613.2% in the second quarter. BB&T Corp now owns 306,125 shares of the company’s stock valued at $22,409,000 after buying an additional 263,205 shares in the last quarter. Finally, WINTON GROUP Ltd purchased a new position in Colgate-Palmolive Company during the third quarter valued at about $2,498,000. Hedge funds and other institutional investors own 71.67% of the company’s stock.
About Colgate-Palmolive Company
Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.